Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer
Status:
Terminated
Trial end date:
2018-12-21
Target enrollment:
Participant gender:
Summary
The purpose of this project is to examine whether treatment with vandetanib has an effect on
the tumor cells in breast cancer by examining tissue markers.